CSI Market
Sign In | Register

Axonics Inc (AXNX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AXNX Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Axonics Inc funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2024)
9 Months 		(Jun 30 2024) (Mar 31 2024) (Dec 31 2023) (Sep 30 2023)
Operating Activities
Income-12.23
Depreciation & amortization9.30
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability0.00
Provision For Loan Losses Expensed0.76
Increase (Decrease) in Inventories-37.62
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation26.39
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
In Process Research And Development Expense-
Increase Decrease In Operating Lease Liability2.48
Payment For Contingent Consideration Liability Operating Activities-
Income taxes4.04
Losses/ -gains on Investments net0.00
Accounts Receivable14.92
Increase (Decrease) in Accounts Payable1.56
Increase (Decrease) in Accrued Liabilities-4.83
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.67
Other Working Capital-0.78
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.02
Discontinued operations0.00
Net Cash flow from Operating Activities8.66
Investing Activities
Capital Expenditures-7.61
Sale of Capital Items0.00
Short-term Investments Proceeds138.80
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities131.19
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock3.01
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issuance Of Preferred Stock And Preference Stock And Noncontrolling Interest-
Stock Issued-
Warrants Issued Debt Issuance Costs-
Accrued Loan Fees Debt Issuance Costs-
Forgiveness of Stock Subscription Receivable-
Stock Issued During Period Value Acquisitions-
Noncash Or Part Noncash Acquisition Contingent Consideration-
Stock Issued During Period Value Exclusive License Asset-
Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities3.01
Effect of exchange rate on cash flow1.14
Discontinued operations0.00
Free Cash Flow1.05
Total Cash Flow144.01
4 historic quarters locked

Sign in to unlock the full Axonics Inc cash flow history.

Sign In Create Free Account

About Axonics Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001603756-24-000077

Figures are derived from filed reports and may be restated. Historical data is subject to revision.